Back

Real-world effectiveness of alirocumab in patients with documented statin intolerance

24 April 2026 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (2) Drug therapy EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Guillermo Villar Ochoa

UNIVERSITY HOSPITAL VIRGEN DE VALME, Seville (Spain)

84 More presentations in this session

Presentation thumbnail
Prediction models for valvular heart disease in the community: a systematic review and meta-analysis
Mr W. Ginks (Leeds, GB)
Abstract Slides
Presentation thumbnail
The prevalence and clinical significance of ecg abnormalities in individuals with a bicuspid aortic valve
Doctor E. Nakou (London, GB)
Abstract Slides
Presentation thumbnail
Arrhythmogenic cardiomyopathy. Prospects for assessing the degree of electrical instability in the damage zone
Professor S. Bondarev (Padua, IT)
Abstract
Presentation thumbnail
Age-stratified predictors of ventricular ectopy in non-ischemic DCM
Mrs N. Hart-Foia (Cluj Napoca, RO)
Abstract Slides
Presentation thumbnail
Cardiopulmonary fitness in patients with a systemic right ventricle: the QUALISYSTEMIC study
Doctor M. Audie (Bordeaux, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster session (2)

The Event

Event poster

ESC Preventive Cardiology 2026

24 April 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Effect of alirocumab on recurrent cardiovascular events after acute coronary syndrome, according to the intensity of background statin treatment
2 September 2019
thumbnail
Congress Presentation
Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel.
31 August 2019
thumbnail
Congress Presentation
Inclisiran patient experiences survey
13 June 2025
thumbnail
Congress Presentation
Effectiveness of PCSK9 inhibitors in homozygous familial hypercholesterolemia: insights from a Saudi Arabia genetic population
3 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources